Abstract
Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis.
Original language | English (US) |
---|---|
Pages (from-to) | 109-122 |
Number of pages | 14 |
Journal | Emergency Medicine Clinics of North America |
Volume | 35 |
Issue number | 1 |
DOIs | |
State | Published - Feb 1 2017 |
Keywords
- Biomarkers
- Lactate
- Proadrenomedullin
- Procalcitonin
- Sepsis
- Troponin
ASJC Scopus subject areas
- Emergency Medicine